Ramabhadra Sarma Mamillapalli

This inventor holds 7 USPTO granted patents. Top assignees: Dr. Reddy's Laboratories, Incorporated, Dr. Reddy's Research Foundation. Active years: 2002-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramabhadra Sarma Mamillapalli. Retrieved from https://idiyas.com/inventor/ramabhadra-sarma-mamillapalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7

% Patents Active = 28.6

Average Co-Inventor Count = 5.1

ph-index = 1

Company Filing History:

7 out of 187

Dr. Reddy's Laboratories, Incorporated

patents

1 out of 23

Dr. Reddy's Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2002-2013

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8377950 - Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt (2013-02-19),

2. 7241895 - Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation (2007-07-10),

3. 7223881 - Process for the preparation of new antidiabetic agents (2007-05-29),

4. 6897199 - Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds (2005-05-24),

5. 6531596 - Process for the preparation of new antidiabetic agents (2003-03-11),

6. 6528507 - Polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them (2003-03-04),

7. 6469167 - Process for the preparation of thiazolidine-2,4-dione derivatives (2002-10-22),

Title: Ramabhadra Sarma Mamillapalli: Innovator in Pharmaceutical Chemistry

Introduction

Ramabhadra Sarma Mamillapalli is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antidiabetic agents. With a total of 7 patents to his name, Mamillapalli has established himself as a key figure in innovative drug formulation.

Latest Patents

Among his latest patents is the invention of a novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt. This invention relates to a pharmaceutical composition that includes this crystalline form along with a pharmaceutically acceptable carrier. The novel crystalline form is noted for its enhanced activity as an antidiabetic agent compared to previously known compounds. Another significant patent involves the polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleate. This invention also includes a pharmaceutical composition that comprises these polymorphic forms, which demonstrate greater efficacy as antidiabetic agents than earlier versions.

Career Highlights

Ramabhadra Sarma Mamillapalli has worked with prominent organizations such as Dr. Reddy's Laboratories and Dr. Reddy's Research Foundation. His experience in these institutions has allowed him to contribute to various innovative projects and research initiatives in the pharmaceutical sector.

Collaborations

Throughout his career, Mamillapalli has collaborated with notable colleagues, including Om Reddy Gaddam and Prabhakar Chebiyyam. These collaborations have further enriched his research and development efforts in the field of pharmaceuticals.

Conclusion

Ramabhadra Sarma Mamillapalli is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in antidiabetic treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]